We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-4.31%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$50.7M
AUM Growth
+$467K
Cap. Flow
+$2.78M
Cap. Flow %
5.5%
Top 10 Hldgs %
63.23%
Holding
28
New
5
Increased
5
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$976K
2
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$564K
3
TYME
Tyme Technologies, Inc. Common Stock
TYME
+$550K
4
DRRX
DURECT Corp
DRRX
+$339K
5
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
+$125K

Top Sells

Rank Stock Value
1
COLL icon
Collegium Pharmaceutical
COLL
+$2.36M
2
MDXG icon
MiMedx Group
MDXG
+$1.56M
3
ALKS icon
Alkermes
ALKS
+$1.41M
4
PFE icon
Pfizer
PFE
+$1.11M
5
GILD icon
Gilead Sciences
GILD
+$1.05M

Sector Composition

Rank Sector Weight
1 Healthcare 73.46%
2 Consumer Staples 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
26
Collegium Pharmaceutical
COLL
$1.17B
– –
-100,000
Closed -$2.36M
IRWD icon
27
CALL
Ironwood Pharmaceuticals
IRWD
$635M
– –
-50,000
Closed -$644K
MDXG icon
28
MiMedx Group
MDXG
$640M
– –
-125,000
Closed -$1.56M
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q3 2021 Portfolio in Review

As of Q3 2021, Healthcare Value Capital held 28 positions worth $50.7M, up 0.93% from $50.2M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Healthcare Value Capital deployed $2.78M of net new capital in Q3 2021, opening 5 new positions and adding to 5 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 5,000 shares worth $907K.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 88% a quarter earlier, followed by Consumer Staples.

On the sell side, the largest reduction was Alkermes, an estimated $1.41M trimmed.

  • Healthcare Value Capital's largest Q3 2021 buy was Vertex Pharmaceuticals: 5,000 shares worth $907K.
  • Healthcare Value Capital added most to Amryt Pharma plc American Depositary Shares in Q3 2021, an estimated $564K increase.
  • Healthcare Value Capital's biggest Q3 2021 reduction was Alkermes, cutting an estimated $1.41M.
  • Healthcare Value Capital fully exited Collegium Pharmaceutical in Q3 2021, selling an estimated $2.36M.
  • Healthcare Value Capital's ten largest holdings make up 63% of its $50.7M portfolio in Q3 2021.
  • Healthcare Value Capital opened 5 new positions and closed 3 in Q3 2021.
  • Healthcare Value Capital's portfolio value rose 0.93% quarter-over-quarter to $50.7M.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.